A therosclerosis is a chronic process that involves a complex interplay between vascular wall cells and inflammatory cells, of which the pathology is characterized by inflammation, lipid accumulation, cell death, and fibrosis. 1, 2 Cigarette smoking is a risk factor for cardiovascular diseases. It has been consistently demonstrated that smoking accelerates the development of atherosclerotic plaques, 3, 4 whereas smoking cessation results in significant decreases of cardiovascular events among smokers. 5 However, quitting tobacco usage is difficult as nicotine plays a critical role in addiction. 6 Moreover, secondhand smoking increases the risk for developing atherosclerosis and acute plaque rupture-related cardiovascular events. 7, 8 There is an urgent need to prevent atherogenesis and cardiovascular events in smokers and individuals exposed to secondhand smoke.
Nicotine is the major component in cigarettes that causes tobacco addiction. 9 Experimental studies demonstrated that nicotine promotes the development of atherosclerosis; however, the specific mechanism by which this occurs remain largely unknown. 10 Effects of mast cells (MCs) have been implicated in nicotine-induced atherosclerotic lesions. For example, mucosal MCs in the respiratory tract are activated by nicotine via cigarette smoking. 11, 12 MCs are important players in innate immunity and exert their biological effects by releasing active components via the degranulation process. MCs play an important role in atherosclerosis, by releasing proteinases and proinflammatory cytokines, and MC-deficient
Results

Nicotine Increases Atherosclerotic Plaque Size and Changes Lesion Content
Apoe −/− mice fed a fat-enriched diet for 12 weeks exhibited typical atherosclerotic lesions not found in those fed a normal diet or wild-type mice fed the fat-enriched diet. Chronic nicotine administration via drinking water accelerates the atherosclerotic process. 9, 10 We found that Apoe −/− mice administered nicotine (delivered via drinking water) showed a significant increase in serum cotinine levels (nicotine versus water alone: 283±33 versus 5±3 ng/mL; P<0.01; Figure IA in the onlineonly Data Supplement). It has been reported that nicotine administered at 100 µg/mL in drinking water yields plasma levels in mice similar to those observed in moderate smokers; average serum cotinine level in moderate smokers is 266 ng/ mL, 9 which is similar to what we found in the present study. No differences were found in systolic blood pressure, body weight, and lipid profiles (data not shown) between vehicle and nicotine groups (Table I in the online-only Data Supplement). Nicotine administration resulted in significantly increased atherosclerotic lesions in the aorta (nicotine versus vehicle: 24.0±4.6 versus 13.2±1.5%; P<0.05; Figure 1A and 1C). To assess regional differences of the lesions, lesion areas were compared for the aortic arch (nicotine versus vehicle: 42.1±3.0 versus 27.1±2.6%; P<0.01; Figure 1A and 1D), descending thoracic region (nicotine versus vehicle: 14.7±3.0 versus 5.2±0.8%; P<0.05; Figure 1A and 1E) and abdominal region (nicotine versus vehicle: 11.2±1.8 versus 5.9±1%; P<0.05; Figure 1A and 1F). Lesion areas in the aortic root was also increased in the nicotine group (nicotine versus vehicle: 21 Figure 1B , 1J, and 1K).
Cross sectioning also showed that nicotine administration increased lesion areas in the aortic arch (nicotine versus Figure IID and IIE in the online-only Data Supplement).
Serum levels of the proinflammatory cytokines, such as interleukin (IL)-6, tumor necrosis factor-α, interferon-γ, and IL-4, were significantly increased in the nicotine group, compared with the vehicle counterparts, whereas the anti-inflammatory cytokine IL-10 showed similar levels in the 2 groups (Supplementary Figure IB through Figure 2A through 2C) were found in the aortic adventitia of the aortic root region. MC activity was assessed via serum levels of histamine and chymase, 2 major components of MC granules, by ELISA. Serum histamine levels were higher in mice administered nicotine (P<0.05; Figure 2D ). Similarly, nicotine significantly increased serum chymase amounts (P<0.01; Figure 2E ). However, no significant difference was observed in serum tryptase levels between the 2 groups ( Figure 2F ).
MC Deficiency Attenuates Nicotine-Induced Plaque Development
MC activation promotes plaque progression, 14 and MC deficiency attenuates atherosclerosis in mice. 18 To further validate the effects of MC activation on nicotine-induced atherosclerotic formation, we assessed whether administration of nicotine would affect atherosclerotic lesions in MC-deficient Apoe −/− Kit w-sh/w-sh mice. After 12 weeks of the same fatenriched diet and nicotine administration, no differences were observed in systolic blood pressure and body weight ( Table I in the online-only Data Supplement), as well as lipid profile (data not shown) and serum cotinine levels ( Figure IA Figure 3B and 3G). Apoe −/− Kit w-sh/w-sh mice had higher collagen (37.3±4.5%; Figure 3B and 3H) and SMC content (17.8±1.2%; Figure 3B and 3I) but displayed less macrophage content (25.7±2.5%; Figure 3B and 3J) and lipid deposit (20.3±1.3%; Figure 3B 
Nicotine Activates MCs in the Aortic Adventitia via α7 Nicotinic Acetylcholine Receptor to Promote Atherogenesis
IgE is considered the most effective activator of MCs. However, non-IgE-mediated MC activation has been documented, with nicotine representing one critical factor in MC activation. 19 In addition, nicotine-induced activation of MCs was demonstrated in guttate psoriasis lesions and stenotic aortic valves in humans. 20, 21 Administration of a nonselective nicotinic acetylcholine receptor (nAChR) antagonist mecamylamine inhibits nicotine-induced MC activation in vitro. [20] [21] [22] To assess mechanisms by which nicotine stimulates MCs, bone marrow-derived MCs (BMMCs) were isolated from Apoe −/− mice and differentiated into mature MCs. The purity of BMMCs was 93.8±0.01% as assessed by toluidine blue staining and 94.6±0.03% by tryptase immunostaining ( Figure IJ and IK in the online-only Data Supplement). β-Hexosaminidase release and histamine release assays were performed to assess degranulation ratios. 23, 24 Supernatants of cultured BMMCs were collected after nicotine stimulation for 0.5, 1, and 2 hours, respectively. BMMCs released ≤48.1±0.5% of total β-hexosaminidase content ( Figure 4A ) and 50.3±0.5% of total histamine content ( Figure 4B) (Figure 4A and 4B) .
To identify the nAChR subunits involved in nicotineinduced MC activation, real-time polymerase chain reaction was performed to quantify the gene expression levels of α3nAChR, α7nAChR, and α9nAChR. α7nAChR mRNA were increased by >100-fold after nicotine stimulation compared with the control group (P<0.01), whereas no significant differences were observed in α3nAChR and α9nAChR mRNA levels ( Figure 4C ). These findings suggest that α7nAChR is an important mediator in nicotine-induced MC activation.
Preincubation with a selective α7nAChR blocker α-bungarotoxin (α-BTX) or genetic suppression of α7nAChR prevented nicotine-induced MC activation, as validated by β-hexosaminidase and histamine release assays ( Figure 4D and 4E). Western blot demonstrated that α7nAChR protein levels were significantly higher after 12 hours of nicotine stimulation and attenuated by the nAChR nonselective blocker mecamylamine and the α7nAChR-selective blocker α-BTX. Taken together, these results indicate that nicotine activates BMMCs through α7nAChR ( Figure 4F and 4G).
Nicotine Activates MCs via the Janus Kinase/Signal Transducer and Activator of Transcription Pathway and Influences Foam Cell Formation In Vitro
The Janus kinase/signal transducer and activator of transcription (JAK-STAT) pathway mediates important responses in immune cells. Although there are 4 members in the mammalian JAK family, JAK2 is best studied in vascular and neuronal tissues. Previous studies have demonstrated that α7nAChR-JAK2-mediated signaling plays a central role in nicotine-induced neuroprotection. 25 BMMCs exposed to nicotine for 2 hours showed phosphorylation of JAK2, STAT3, and Akt, all of which could be restored by preincubation with the nAChR nonselective blocker mecamylamine or the α7nAChR-selective blocker α-BTX ( Figure 5A through 5D) . These results demonstrated that nicotine-induced MC activation was mediated through JAK2 phosphorylation and subsequent activation of STAT3 and Akt, leading to MC degranulation and enhanced cytokine production. 19, 26, 27 To assess the effects of nicotine-induced MC activation on macrophages, peritoneal macrophages were incubated with conditional supernatants from MCs. Real-time polymerase chain reaction demonstrated that stimulation with supernatants from nicotine-activated MCs resulted in decreased expression levels of ATP-binding membrane cassette transporter A1 and ATP-binding membrane cassette transporter G1 ( Figure 5E and 5F). Meanwhile, CD36 levels ( Figure 5G ) and the amounts of proinflammatory cytokines IL-6, monocyte chemotactic BMMCs were incubated with nicotine for 0.5 h, 1 h, and 2 h, respectively. Then, supernatants were collected for β-hexosaminidase and histamine assessments. F and G, α7nAChR protein expression levels in BMMCs incubated with Tyrode buffer, nicotine, nicotine+mecamylamine (pretreatment for 30 min), or nicotine+α-BTX (pretreatment for 30 min) incubated for 12 h. Protein levels were assessed by Western blotting; quantitative analysis of α7nAChR expression was performed by 1-way ANOVA. protein-1, interferon-γ, and tumor necrosis factor-α ( Figure 5H through 5K) were increased in macrophages. IL-10 levels did not change ( Figure 5L ). Western blotting demonstrated that matrix metalloproteinase-2 and matrix metalloproteinase-9, which cause collagen degradation in atherosclerotic lesions, were also increased by incubation with supernatants from nicotine-activated MCs (Figure 5M through 5O) .
Similarly After 12 weeks of fat-enriched diet feeding and nicotine administration, no differences were observed in systolic blood pressure and body weight ( Table I in Figure 6B , 6L, and 6M).
Genetic Deficiency of α7nAChR in MCs or Pharmacological Stabilization of MCs Attenuates Nicotine-Induced Atherosclerosis
Discussion
Nicotine enhances atherogenesis in Apoe −/− mice fed a fatenriched diet. Nicotine increases MC number and activates MCs in the adventitia of the atherosclerosis-prone regions by releasing proinflammatory cytokines and proteinases. 19, [29] [30] [31] Nicotine increases macrophage content and lipid deposition but diminishes SMC and collagen contents in atherosclerotic lesions.
Although the association of nicotine with atherosclerosis has been recognized for decades, no approach effectively protects individuals exposed to cigarette smoking from developing atherosclerosis. More than 4000 chemicals have been found in cigarettes, but nicotine is considered the major contributor to cigarette addiction and adverse cardiovascular events. Nicotine in cigarettes can be rapidly absorbed through the alveoli and small airways, entering the circulation through the pulmonary fluid. Similarly, nicotine could be absorbed through the oral mucosa and small intestine. Nicotine was found to promote atherosclerosis, nonrheumatic aortic stenosis, and psoriasis, and increased activation and accumulation of MCs are found in lesions of these diseases. 10, 20, 21 The role of MCs in atherosclerosis has been identified recently. Both increased quantity and activation of MCs are observed in atherosclerotic plaques and the adventitia of human aortas and coronary arteries. MC progenitors originate from hematopoietic stem cells, which circulate throughout the body, eventually homing in tissues; maturing human MCs also exhibit heterogeneity and are classified by serine protease content as tryptase-only MC, chymase-only MC, and both tryptase-and chymase-positive MC. However, no studies have assessed the effects of MC subgroups on atherosclerosis.
32 Figure 5 Continued. cassette transporter G1 (ABCG1) expression in macrophages. A, Bone marrow-derived mast cells (BMMCs) were exposed to 100 μg/mL nicotine for 2 h. Phosphorylation levels of JAK2, STAT3, and Akt were determined by Western blotting, and β-actin was used as a loading control. B-D, Quantitative analysis of JAK2, STAT3, and Akt phosphorylation levels were analyzed with 1-way ANOVA. E-L, mRNA expression levels of ABCA1 and ABCG1, CD36, interleukin (IL)-6, monocyte chemotactic protein-1 (MCP-1), interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and IL-10 in peritoneal macrophages incubated with conditional supernatants were assessed by real-time polymerase chain reaction. M, MMP-2 and MMP-9 expression levels in peritoneal macrophages incubated with conditional supernatants collected from the MC activation assay were assessed by Western blotting. N and O, Quantitative analysis of MMP-2 and MMP-9 expression levels of peritoneal macrophages. Values are mean±SEM. Mature MCs achieve their biological activity via degranulation, a process whereby cells release their intragranular contents into the extracellular space. In the lungs and skin of smokers, MC number and activation are increased. 11, 12 In this study, we focused on aortic adventitial MCs for a morphological evaluation of degranulation. It should be pointed out that the serum degranulation effect comes not only from MCs in the arteries but also from those in other locations such as the respiratory epithelium or skin.
Newly released clinical data from the Multi-Ethnic Study of Atherosclerosis showed that persistent asthmatics have a higher incidence of cardiovascular diseases compared with nonasthmatics, suggesting the possibility that MCs act as a mediator for respiratory and cardiovascular diseases. 33 Herein, we assessed the role of MCs in nicotineinduced atherosclerosis and observed the effects of MC deficiency or pharmacological stabilization on nicotine-induced atherosclerosis.
Supernatants from conditioned MC cultures promoted foam cell formation of macrophages. The underlying mechanism may involve decreased mRNA expression of macrophage ATP-binding cassette transporters, ATP-binding membrane cassette transporter A1 and ATP-binding membrane cassette transporter G1, and increased mRNA expression of scavenger receptor CD36, which suggests both increased cholesterol uptake and impaired cholesterol efflux of the macrophages. 34, 35 The expression levels of a variety of proinflammatory cytokines, including interferon-γ, IL-6, monocyte chemotactic protein-1, and tumor necrosis factor-α, were increased in activated peritoneal macrophages incubated with supernatants from conditioned MCs. Matrix metalloproteinase-2 and matrix metalloproteinase-9, the most potent proteinases for collagen degradation, also showed increased amounts in macrophages incubated with conditional MC supernatants. Increased lipid accumulation, matrix degradation, and inflammation all contribute to accelerated atherogenesis. 36 nAChRs are mainly expressed in the central nervous system. However, recent studies reported their presence and biological activities in a variety of non-neuronal cells, including MCs. 37 Given that nicotine can dramatically increase α7nAChR expression in MCs, the relationship between α7nAChR and nicotine-induced MC activation was assessed. α7nAChR-deficient MCs showed protection from nicotineinduced atherosclerosis. Similarly, MCs incubated with either a nonselective nAChRs blocker mecamylamine or a α7nAChR-selective blocker α-BTX had no nicotine-induced MC activation. Similarly, a MC stabilizer DSCG attenuated nicotine-induced MC activation. Our in vivo study showed protective effects of DSCG, as evidenced by decreased plaque burden and improved preservation of plaque components. These data strongly suggest a potential therapeutic application of DSCG in individuals exposed to cigarette smoke. Although protection from nicotine-enhanced atherosclerosis by DSCG treatment is suggestive, it is not known whether DSCG in this model affects atherosclerosis independent of nicotine-induced MC activation. Phosphorylation levels of JAK2, STAT3, and Akt were increased in MCs after a 2-hour nicotine stimulation but inhibited by the nonselective nAChR blocker mecamylamine and the α7nAChR-specific blocker α-BTX. These results suggest that nicotine activates α7nAChR and exerts its effects through the downstream JAK2/STAT3 and PI3K (phosphoinositide 3-kinase)/Akt signaling pathways. However, Barua et al 39 have reported that the histamine-TLR-COX-2 axis is also involved in MC activation by cigarette smoke. Therefore, the histamine-TLR-COX-2 (toll-like receptor-cyclooxygenase-2) axis may also be a potential mechanism, which needs further studies.
The present study showed that, in vitro and in vivo, depletion and stabilization of MCs could not fully reverse nicotine-induced foam cell formation and atherosclerosis. Therefore, activation of MCs may represent only one of the mechanisms by which nicotine accelerates atherosclerosis. According to previous studies, other mechanisms may include (1) direct enhancement of CD36 expression on macrophages; (2) induction of angiogenesis and increased neovascularization; and (3) increased oxidative stress. 9, 40, 41 In this case, MC stabilization therapy may not be enough in smokers experiencing atherosclerotic diseases.
In summary, we have demonstrated that MCs play an important role in nicotine-enhanced atherogenesis in Apoe −/− mice. Nicotine activated MCs in the aortic adventitia via an α7nAChR-mediated mechanism. Nicotine induces JAK2 phosphorylation, triggers STAT3 phosphorylation and PI3K-mediated activation of Akt, which contribute to MC degranulation and proinflammatory cytokine production and release. 19, 42 MC stabilization or nAChR depletion attenuates nicotineinduced atherosclerosis. These findings provide a potential therapeutic strategy for reducing atherosclerotic plaque progression and preventing cardiovascular events in individuals exposed to cigarette smoke.
